Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
Jakacki RI, Cohen BH, Jamison C, Mathews VP, Arenson E, Longee DC, Hilden J, Cornelius A, Needle M, Heilman D, Boaz JC, Luerssen TG.
Jakacki RI, et al.
J Neurosurg. 2000 Feb;92(2):255-60. doi: 10.3171/jns.2000.92.2.0255.
J Neurosurg. 2000.
PMID: 10659012
Clinical Trial.